Bacterial Vaginosis and Solosec Trials [transcript] [audio]

Guest: Dr. Paul Nyirjesy

Presenter: Neal Howard

Guests Bio: Paul Nyirjesy, MD, is Professor of Obstetrics & Gynecology, Drexel University College of Medicine, Philadelphia, PA. Dr. Nyirjesy is the director of the Drexel Vaginitis Center and also serves as an attending physician at Hahnemann University Hospital. Dr. Nyirjesy has been a consultant on the Centers for Disease Control’s guidelines on sexually transmitted diseases treatment since 2005 and wrote the American Congress of Obstetricians and Gynecologists’ most recent guidelines on vaginitis. He has served as on the Medical-Scientific Advisory Board of the National Vulvodynia Association since 2002.

Segment overview: Dr. Paul Nyirjesy, MD, Professor of Obstetrics & Gynecology at Drexel University College of Medicine and an investigator in the Solosec(secnidazole) oral granules clinical trial discusses the findings of that trial and the recent FDA approval.

0 Comments

Leave a Reply

You must be logged in to post a comment.